GlassScriptPhysician profile
Jennifer K Hare
NPI 1336431402
$2,027.44
in general payments reported to CMS, 2019-2025
12 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $277 · 2023: $516 · 2024: $657 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,305 · Grant: $87.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.95 |
| Grant | $87.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $821.00 | 2021-2025 | Farxiga, Brilinta, Lokelma |
| Medtronic, INC. | $373.84 | 2021-2024 | Corevalve Evolut R, Interstim, Cobalt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $180.11 | 2021-2025 | Eliquis |
| Shockwave Medical, INC | $176.23 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $129.06 | 2021-2023 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Viewmate |
| Abiomed | $119.38 | 2024-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.59 | 2023-2025 | Jardiance |
| Teleflex LLC | $45.70 | 2024 | Guideliner |
| Novo Nordisk INC | $41.97 | 2023-2024 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.13 | 2024 | Lifevest |
| Becton, Dickinson and Company | $24.05 | 2024 | Lutonix Drug Coated Balloon |
| Cardiva Medical, INC. | $17.38 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.